Identification of differentially expressed genes in mouse hepatocarcinoma ascites cell line with low potential of lymphogenous metastasis

World Journal of Gastroenterology

Volumn 12, Issue 42, 2006, Pages 6893-6897

  Cui, Xiao Nan ^a   Tang, Jian Wu ^a   Hou, Li ^a   Song, Bo ^a   Ban, Li Ying ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Liver neoplasm; Metastasis suppression genes; Suppression subtracted hybridization

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES TUMOR CELL; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE IDENTIFICATION; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOLECULAR CLONING; MOUSE; NONHUMAN; SEQUENCE HOMOLOGY; SUBTRACTIVE HYBRIDIZATION;

EID: 33751353423     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i42.6893     Document Type: Article

References (33)

1. Ji Y, Ling MY, Li Y, Xie H. Effect of cell fusion on metastatic ability of mouse hepatocarcinoma cell lines. World J Gastroenterol 1999; 5: 22-24
2. Diatchenko L, Lukyanov S, Lau YF, Siebert PD. Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Methods Enzymol 1999; 303: 349-380
3. von Stein OD, Thies WG, Hofmann M. A high throughput screening for rarely transcribed differentially expressed genes. Nucleic Acids Res 1997; 25: 2598-2602
4. Karlseder J. Telomere repeat binding factors: keeping the ends in check. Cancer Lett 2003; 194: 189-197
5. Deng Z, Atanasiu C, Burg JS, Broccoli D, Lieberman PM. Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J Virol 2003; 77: 11992-12001
6. Wu G, Jiang X, Lee WH, Chen PL. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. Cancer Res 2003; 63: 2589-2595
7. Iwano T, Tachibana M, Reth M, Shinkai Y. Importance of TRF1 for functional telomere structure. J Biol Chem 2004; 279: 1442-1448
8. Kishi S, Lu KP. A critical role for Pin2/TRF1 in ATM-dependent regulation. Inhibition of Pin2/TRF1 function complements telomere shortening, radiosensitivity, and the G(2)/M checkpoint defect of ataxia-telangiectasia cells. J Biol Chem 2002; 277: 7420-7429
9. Iizuka N, Mori N, Tamesa T, Tangoku A, Oka M. Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma. Anticancer Res 2003; 23: 43-47
10. Nosaka K, Kawahara M, Masuda M, Satomi Y, Nishino H. Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. Biochem Biophys Res Commun 1998; 243: 342-348
11. Li B, de Lange T. Rap1 affects the length and heterogeneity of human telomeres. Mol Biol Cell 2003; 14: 5060-5068
12. Yang SW, Kim DH, Lee JJ, Chun YJ, Lee JH, Kim YJ, Chung IK, Kim WT. Expression of the telomeric repeat binding factor gene NgTRF1 is closely coordinated with the cell division program in tobacco BY-2 suspension culture cells. J Biol Chem 2003; 278: 21395-21407
13. Yamada K, Yagihashi A, Yamada M, Asanuma K, Moriai R, Kobayashi D, Tsuji N, Watanabe N. Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells. Anticancer Res 2002; 22: 1315-1320
14. Otsuka T, Uchida N, Arima F, Shigematsu H, Fukuyama T, Maeda M, Sugio Y, Itoh Y, Niho Y. Down-regulation of human telomeric protein TRF1 gene expression during myeloid differentiation in human hematopoietic cells. Int J Hematol 2000; 71: 334-339
15. Fujimoto R, Kamata N, Taki M, Yokoyama K, Tomonari M, Nagayama M, Yasumoto S. Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells. Oral Oncol 2003; 39: 445-452
16. Saito K, Yagihashi A, Nasu S, Izawa Y, Nakamura M, Kobayashi D, Tsuji N, Watanabe N. Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer. Jpn J Cancer Res 2002; 93: 253-258
17. Yamada M, Tsuji N, Nakamura M, Moriai R, Kobayashi D, Yagihashi A, Watanabe N. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Anticancer Res 2002; 22: 3303-3307
18. Miyachi K, Fujita M, Tanaka N, Sasaki K, Sunagawa M. Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer. J Exp Clin Cancer Res 2002; 21: 269-275
19. Dokras A, Gardner LM, Kirschmann DA, Seftor EA, Hendrix MJ. The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development. Placenta 2002; 23: 274-280
20. Ngamkitidechakul C, Warejcka DJ, Burke JM, O'Brien WJ, Twining SS. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J Biol Chem 2003; 278: 31796-31806
21. Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nat Med 2000; 6: 196-199
22. Biliran H Jr, Sheng S. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res 2001; 61: 8676-8682
23. Zhang W, Zhang M. Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in various tumors. Int J Oncol 2002; 20: 1145-1150
24. Khalkhali-Ellis Z, Hendrix MJ. Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells. Am J Pathol 2003; 162: 1411-1417
25. Maass N, Teffner M, Rosel F, Pawaresch R, Jonat W, Nagasaki K, Rudolph P. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 2001; 195: 321-326
26. Chen Z, Fan Z, McNeal JE, Nolley R, Caldwell MC, Mahadevappa M, Zhang Z, Warrington JA, Stamey TA. Hepsin and maspin are inversely expressed in laser capture microdissertioned prostate cancer. J Urol 2003; 169: 1316-1319
27. Manzotti M, Dell'Orto P, Maisonneuve P, Zurrida S, Mazzarol G, Viale G. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer 2001; 95: 307-312
28. Maass N, Hojo T, Rosel F, Ikeda T, Jonat W, Nagasaki K. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 2001; 34: 303-307
29. Sabbatini R, Federico M, Morselli M, Depenni R, Cagossi K, Luppi M, Torelli G, Silingardi V. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J Clin Oncol 2000; 18: 1914-1920
30. Machtens S, Serth J, Bokemeyer C, Bathke W, Minssen A, Kollmannsberger C, Hartmann J, Knuchel R, Kondo M, Jonas U, Kuczyk M. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 2001; 95: 337-342
31. Yasumatsu R, Nakashima T, Hirakawa N, Kumamoto Y, Kuratomi Y, Tomita K, Komiyama S. Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 2001; 23: 962-966
32. Cui XN, Tang JW, Hou L, Song B, Li L, Liu JW. Screening differentially expressed genes in mouse hepatocarcinoma ascites cell line with high potential of lymphatic metastasis. World J Gastroenterol 2005; 11: 1837-1842
33. Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, Merril CR, Wu A, Olde B, Moreno RF. Complementary DNA sequencing: expressed sequence tags and human genome project. Science 1991; 252: 1651-1656